Comparing a new diabetes drug to semaglutide
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests a new medication, RAY1225, against a standard treatment (semaglutide) for people with type 2 diabetes who already take oral diabetes pills. It aims to see if RAY1225 can help manage blood sugar better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with type 2 diabetes.
- Your average blood sugar level (HbA1c) is between 7.0% and 11.5%.
- Your body mass index (BMI) is at least 20.
- Your weight has not changed much (within 5%) for at least 3 months.
- You do not have type 1 diabetes or serious diabetes complications.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new medicine called RAY1225 for people with type 2 diabetes who are not on diabetes drugs. It aims to see if the medicine can help control blood sugar and weight.
This study compares a weekly injection called semaglutide with a calorie-restricted diet to see which helps control blood sugar better. If you have just been diagnosed with type 2 diabetes and have overweight, this trial might help you choose a treatment path.
This study tests a new medicine, NNC0662-0419, in people with type 2 diabetes. You must be willing to lose a lot of weight (more than a quarter of your current weight) as part of the study to see if the medicine helps lower blood sugar.
This study tests if starting two newer diabetes drugs (empagliflozin and semaglutide) soon after diagnosis, along with metformin, helps control blood sugar better than metformin alone. It's for people diagnosed with type 2 diabetes in the last two years who are already taking a high dose of metformin.
This study tests if adding LY3457263 helps lower blood sugar in people with type 2 diabetes who are already taking a stable dose of semaglutide or tirzepatide. You will be randomly assigned to get either LY3457263 or a placebo.
This trial tests if a new form of semaglutide works as well as the approved drug Ozempic for lowering blood sugar. It's for adults with type 2 diabetes who are already taking metformin and need better sugar control.
Hear when a new T2DM trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.